Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2025-09-26

EMA Authorised: Tigecycline Accord (tigecycline) — Accord Healthcare S.L.U.

View source ↗

Summary

The European Medicines Agency authorised Tigecycline Accord (tigecycline) for use by Accord Healthcare S.L.U. for soft tissue infections, intraabdominal infecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tigecycline Accord (tigecycline)

Snippet

Status: Authorised. Therapeutic area: Soft Tissue Infections;Intraabdominal Infections;Bacterial Infections;Skin Diseases, Infectious. MAH: Accord Healthcare S.L.U.. Decision date: 25/09/2025